{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:15:09Z","timestamp":1773904509440,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/hr.2014.144","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T05:56:55Z","timestamp":1411624615000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial"],"prefix":"10.1038","volume":"38","author":[{"name":"for the COLM investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Ogihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"BFhr2014144_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ, HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. New Engl J Med 2008; 358: 1887\u20131898.","journal-title":"New Engl J Med"},{"key":"BFhr2014144_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderrisi M, Grobbee D, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Simes PA, Sleight P, Viigimaa M, Waeber B, Zannad F . ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281\u20131357.","journal-title":"J Hypertens"},{"key":"BFhr2014144_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito I, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Takahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S on behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014; 37: 253\u2013392.","journal-title":"Hypertens Res"},{"key":"BFhr2014144_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegre O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Narva AS, Ortiz E . 2014 Evidence-based guideline for management of high blood pressure in adults. Repaot from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507\u2013520.","journal-title":"JAMA"},{"key":"BFhr2014144_CR5","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"369","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, Heste A, Gupte J, Gatlin M, Velazquez EJ . ACCOMPLISH Trial investigators. Benazepril plus amlodipine or hydrochrolothiazide for hypertension in high-risk patients. New Engl J Med 2008; 369: 2417\u20132428.","journal-title":"New Engl J Med"},{"key":"BFhr2014144_CR6","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/HJH.0b013e328348345d","volume":"29","author":"M Matsuzaki","year":"2011","unstructured":"Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y Saruta T . Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. J Hypertens 2011; 29: 1649\u20131659.","journal-title":"J Hypertens"},{"key":"BFhr2014144_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/hr.2008.31","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Saruta T, Rakugi H, Shimamoto K, Ito S, Matsuoka H, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Saito I, Shimada K on behalf of the COLM study investigators. Rationale, study design and implementation of the COLM study: the Combination of OLmesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients. Hypertens Res 2009; 32: 163\u2013167.","journal-title":"Hypertens Res"},{"key":"BFhr2014144_CR8","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/HJH.0000000000000281","volume":"32","author":"T Ogihara","year":"2014","unstructured":"Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahahi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S for the COLM Investigators. Combinations of olmesartan and a calcium channel blocker or adiuretic in elderly hypertensive patients: a randomized, controlled trial. J. Hypertens 2014; 32: 2054\u20132063.","journal-title":"J. Hypertens"},{"key":"BFhr2014144_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jash.2010.02.005","volume":"4","author":"AH Gradman","year":"2010","unstructured":"Gradman AH, Basile JN, Carter BL, Bakris GL . American Society of Hypertension Writing Group. Combination therapy in hypertension. J Am Soc Hypertens 2010; 4: 42\u201350.","journal-title":"J Am Soc Hypertens"},{"key":"BFhr2014144_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/hr.2011.216","volume":"34","author":"T Ogihara","year":"2012","unstructured":"Ogihara T, Matsuzaki M, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T for the Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Combination therapy for hypertension in the elderly: a sub-analysis of the Combonation THerapy to Prevent Cardiovascular Events (COPE) Trial. Hypertens Res 2012; 34: 441\u2013448.","journal-title":"Hypertens Res"},{"key":"BFhr2014144_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/HJH.0b013e328342c845","volume":"29","author":"DJ Collier","year":"2011","unstructured":"Collier DJ, Poulter NR, Dahlof B, Sever PS, Wedel H, Buch J, Caulfield MJ, ASCOT Investigators. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). J Hypertens 2011; 29: 583\u2013591.","journal-title":"J Hypertens"},{"key":"BFhr2014144_CR12","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"F Turnbull","year":"2003","unstructured":"Turnbull F Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527\u20131535.","journal-title":"Lancet"},{"key":"BFhr2014144_CR13","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981\u20132997.","journal-title":"JAMA"},{"key":"BFhr2014144_CR14","first-page":"1121","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Blood Pressure Lowering Treatment Trialists' Collaboration, Blood Pressure Lowering Treatment Trialists' Collaboration Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration Neal B, Blood Pressure Lowering Treatment Trialists' Collaboration Ninomiya T, Blood Pressure Lowering Treatment Trialists' Collaboration Algert C, Blood Pressure Lowering Treatment Trialists' Collaboration Arima H, Blood Pressure Lowering Treatment Trialists' Collaboration Barzi F, Blood Pressure Lowering Treatment Trialists' Collaboration Bulpitt C, Blood Pressure Lowering Treatment Trialists' Collaboration Chalmers J, Blood Pressure Lowering Treatment Trialists' Collaboration Fagard R, Blood Pressure Lowering Treatment Trialists' Collaboration Gleason A, Blood Pressure Lowering Treatment Trialists' Collaboration Heritier S, Blood Pressure Lowering Treatment Trialists' Collaboration Li N, Blood Pressure Lowering Treatment Trialists' Collaboration Perkovic V, Blood Pressure Lowering Treatment Trialists' Collaboration Woodward M, Blood Pressure Lowering Treatment Trialists' Collaboration MacMahon S . Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121\u20131123.","journal-title":"BMJ"},{"key":"BFhr2014144_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.109.131466","volume":"54","author":"Y Matsui","year":"2009","unstructured":"Matsui Y, Eguchi K, \u00d2Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K . Differentia effects between a calcium channel blocker and diuretic when used in combination with angiotensinII receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54: 716\u2013723.","journal-title":"Hypertension"},{"key":"BFhr2014144_CR16","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.111.189217","volume":"59","author":"Y Matsui","year":"2012","unstructured":"Matsui Y, \u00d2Rourke MF, Hoshide S, Matsui Y, Shimada K, Kario K . Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan combined treatment with olmesartan and a calcium channel blocker versus olmesartan and diuretics randomized efficacy study. Hypertension 2012; 59: 1132\u20131138.","journal-title":"Hypertension"},{"key":"BFhr2014144_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","volume":"375","author":"AJ Webb","year":"2010","unstructured":"Webb AJ, Fischer U, Mehta Z, Rothwell PM . Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906\u2013915.","journal-title":"Lancet"},{"key":"BFhr2014144_CR18","doi-asserted-by":"crossref","first-page":"e000668","DOI":"10.1161\/JAHA.113.000668","volume":"3","author":"JE Ho","year":"2014","unstructured":"Ho JE, Larson MG, Ghorbani A, Chen S, Coglianese EE, Vasan RS, Wang TJ . Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc 2014; 3: e000668.","journal-title":"J Am Heart Assoc"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2014144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2014144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2014144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:46Z","timestamp":1684430026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2014144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFhr2014144"],"URL":"https:\/\/doi.org\/10.1038\/hr.2014.144","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]},"assertion":[{"value":"27 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report receiving lecture fees and\/or research grants from various pharmaceutical companies in Japan, including Daiichi Sankyo.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}